|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 双差定位法在地震丛集精确定位中的应用显示文摘应用双差定位方法(hypodd)对北美Loma Prieta地区的分属于3个地震丛集的47个地震进行了精确定位.采用交叉谱法精确求取信号的走时差;同时采用人机联做方式在时域调整、修正按自动方式无法准确提取时差的信号,确保每个事件对的走时差精度.重定位后,在几百米的范围内,原来相互重叠的震源位置聚集为三个明显分离的丛集;水平方向的相对位置平均误差为8.5米,震源深度方向的平均误差为23.4 m. | 刘劲松 Kin-Yip Chun Gary A.Henderson 刘福田 郝天珧 | 2007 | 地球物理学进展2007，22，1： | 23 |
| 2 | Relative in vitro efficacy of the phosphate binders lanthanum carbonate and sevelamer hydrochloride显示文摘 | ValerieAutissier Stephen J.P.Damment Richard A.Henderson | 2007 | J. Pharm. Sci2007，，10： | 1 |
| 3 | Multi-watt near-infrared light therapy as a neuroregenerative treatment for traumatic brain injury显示文摘Infrared light represents a broad spectrum of light with wavelengths from 700 nm to 1 million nm(1,000 microns).At its shortest wavelengths(referred to as near-infrared),it merges with the red spectrum of visible light.At the longest end(referred to as far-infrared),it blends into the range of microwaves. | Theodore A.Henderson | 2016 | Neural Regeneration Research2016，11，4： | 1 |
| 4 | 'Rewriting'Cultural Safety within the Postcolonial and Postnational Feminist Project:Toward New Epistemologies of Healing显示文摘 | Anderson J.P J.Perry C.Blue A.Henderson and K.Khan | | 0，，03： | 1 |
| 5 | The Quiet Revolution显示文摘 | James A.Henderson Jr Theodore Eisenherg | | 0，，： | 1 |
| 6 | Practical application of the neuroregenerative properties of ketamine: real world treatment experience显示文摘While controversial, ketamine has emerged as an effective treatment for refractory depression. Serial infusions have been performed 3 times per week, but our practical experience has challenged this precept concerning infusion frequency. Depression is associated with neuron loss, reduced synapse numbers, and dearborization of dendrites. Ketamine appears to potently induce mechanisms which reverse these neurodegenerative processes. Ketamine not only blocks the glutamate receptor, it activates eukaroyotic elongation factor 2(e EF2). This, in turn, activates brain-derived neurotrophic factor(BDNF) protein synthesis. This is thought to underlie ketamine's enduring benefits. In addition, ketamine alters glycogen synthase kinase-3(GSK-3) phosphorylation, probably responsible for its rapid antidepressant effect. Notably, inhibition of the BDNF receptor does not block the immediate benefits of ketamine, but does prevent the enduring effects. Neuro-Luminance Ketamine Infusion Centers have been treating patients with serial ketamine infusions for over three years. Our methods differ from what is often reported, as we perform infusions only once per week and generally do not perform more than five infusions. Data from 100 patients showed that 80% of the patients responded. The baseline Quick Inventory of Depressive Symptomatology-Self Report(QIDS-SR) score was 17.8 ± 2.8. Responders to ketamine showed a drop in QIDS-SR score of 10.8 ± 3.5, while non-responders showed a 0.8 ± 1.8 change. Moreover, they often had persistent benefits over several months. Recently, it was proposed that psychotomimetic effects are necessary during a ketamine infusion to yield effective antidepressant benefits. Yet, only one patient in our clinic has experienced hallucinations in three years. Nevertheless, 80% of our patients show clinical improvement. Further studies of clinical methods for ketamine infusion therapy are encouraged. | Theodore A.Henderson | 2016 | Neural Regeneration Research2016，11，2： | 0 |
| 7 | 药品设计是不同的显示文摘在一篇题为《〈侵权行为法重述(第三次):产品责任〉中有设计缺陷吗?》论文中,George Conk批评美国法律协会和新重述的报告人免除处方药制造者设计缺陷责任。本文是新重述的报告人对他和其他批评者的一个回应。本文第一部分概述Conk的论文,包括他对新重述的解释。第二部分指出Conk批评中的重大错误:他误读了重述,而且他对血液案例的依靠是错位的。第三部分解释新重述对处方药品设计的处理和它对产品设计缺陷的一般处理之间的实质性的差别并使之正当化。这些差别包括新重述拒绝允许法院去考虑尚未得到FDA许可的可替代的更安全的处方产品(在一般设计条款下,法院通常是考虑尚未上市的替代性设计的)和拒绝牺牲一类患者的福利去增进另一类患者的福利(在一般设计条款下,这种消费者之间的相互利益牺牲通常是得到宽容的。第三部分也解释为什么药品设计诉讼不能通过减少其复杂性而合法地被变得更有利于原告,以及为什么新重述的规定不会明显地降低制造者发现新的、更加安全的处方产品的积极性。 | Aaron D.Twerski 宋工(译) 杜颖(校) | 2002 | 私法2002，，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员